IBM wants to help researchers better understand and treat COVID-19. To do so, it’s putting its AI to work. It has released a series of new tools to aggregate data, help researchers explore potential therapies, advance the study of newly sequenced SARS-CoV-2 genomes and make the latest info available to healthcare professionals.
Its AI deep search tool is ingesting data from the White House, a coalition of research groups and licensed databases from the DrugBank, Clinicaltrials.gov and GenBank. Qualified researchers can pose queries, and using machine learning, the system will quickly extract relevant information from the 13,335 documents that the tool currently includes. IBM says it’s capable of adding as many as 100,000 PDFs per day.